Page last updated: 2024-08-24

tiludronic acid and Osteoporosis, Postmenopausal

tiludronic acid has been researched along with Osteoporosis, Postmenopausal in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (70.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arlot, ME; Delmas, PD; Meunier, PJ; Nilssen, MH; Pastoureau, P; Vergnaud, P	1
Ammann, P; Bonjour, JP; Caverzasio, J; Rizzoli, R; Shigematsu, T; Slosman, D	1
Chesnut, CH	1
Reginster, JY	2
Licata, AA	1
Andreassen, H; Bidstrup, M; Clemmesen, B; Gunnes, M; Ravn, P; Rix, M	1
Papapoulos, SE	1
Watts, NB	1
Christiansen, C; Fechtenbaum, J; Reginster, JY; Rouillon, A; Roux, C; Tou, KP	1

Reviews

6 review(s) available for tiludronic acid and Osteoporosis, Postmenopausal

Article	Year
Tiludronate: development as an osteoporosis therapy. Bone, 1995, Volume: 17, Issue:5 Suppl Topics: Animals; Biomarkers; Bone Density; Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Double-Blind Method; Female; Humans; Ilium; Multicenter Studies as Topic; Osteoporosis, Postmenopausal; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	1995
[Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis]. Journal de gynecologie, obstetrique et biologie de la reproduction, 1996, Volume: 25, Issue:7 Topics: Bone Density; Calcitonin; Cost-Benefit Analysis; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Mass Screening; Osteoporosis, Postmenopausal; Risk Factors	1996
Bisphosphonate therapy. The American journal of the medical sciences, 1997, Volume: 313, Issue:1 Topics: Alendronate; Animals; Bone Density; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid	1997
Bisphosphonates in the treatment of osteoporosis. Principles and efficacy. Annales de medecine interne, 2000, Volume: 151, Issue:6 Topics: Administration, Oral; Alendronate; Animals; Bone and Bones; Bone Density; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Diphosphonates; Etidronic Acid; Female; Hip Fractures; Humans; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Papio; Prospective Studies; Randomized Controlled Trials as Topic; Risedronic Acid; Spinal Fractures; Time Factors	2000
Treatment of osteoporosis with bisphosphonates. Rheumatic diseases clinics of North America, 2001, Volume: 27, Issue:1 Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid	2001
Oral tiludronate: pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis. Bone, 1992, Volume: 13, Issue:5 Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Dogs; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Mice; Osteitis Deformans; Osteoporosis, Postmenopausal; Papio; Rats; Tissue Distribution	1992

Trials

2 trial(s) available for tiludronic acid and Osteoporosis, Postmenopausal

Article	Year
High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcified tissue international, 1997, Volume: 60, Issue:3 Topics: Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Cross-Sectional Studies; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoassay; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Reagent Kits, Diagnostic; Spinal Fractures; Thoracic Vertebrae	1997
Intermittent cyclic tiludronate in the treatment of osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2001, Volume: 12, Issue:3 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Collagen; Creatine; Diphosphonates; Double-Blind Method; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Spinal Fractures; Treatment Outcome	2001

Article

Year

High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women.

Calcified tissue international, 1997, Volume: 60, Issue:3

Topics: Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Bone Development; Bone Resorption; Cross-Sectional Studies; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoassay; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Reagent Kits, Diagnostic; Spinal Fractures; Thoracic Vertebrae

1997

Intermittent cyclic tiludronate in the treatment of osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2001, Volume: 12, Issue:3

Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Collagen; Creatine; Diphosphonates; Double-Blind Method; Female; Humans; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Spinal Fractures; Treatment Outcome

2001

Other Studies

2 other study(ies) available for tiludronic acid and Osteoporosis, Postmenopausal

Article	Year
The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone, 1995, Volume: 16, Issue:6 Topics: Alkaline Phosphatase; Amino Acids; Analysis of Variance; Animals; Biomechanical Phenomena; Bone Density; Bone Development; Bone Resorption; Diphosphonates; Disease Models, Animal; Female; Humans; Hydroxyproline; Ilium; Injections, Subcutaneous; Osteocalcin; Osteoclasts; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Sheep; Teriparatide	1995
Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:12 Topics: Animals; Benzoates; Bone Density; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Intestinal Absorption; Male; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroidectomy; Rats; Rats, Sprague-Dawley; Rats, Wistar; Retinoids; Thyroidectomy	1993

Article

Year

The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?

Bone, 1995, Volume: 16, Issue:6

Topics: Alkaline Phosphatase; Amino Acids; Analysis of Variance; Animals; Biomechanical Phenomena; Bone Density; Bone Development; Bone Resorption; Diphosphonates; Disease Models, Animal; Female; Humans; Hydroxyproline; Ilium; Injections, Subcutaneous; Osteocalcin; Osteoclasts; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Sheep; Teriparatide

1995

Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:12

Topics: Animals; Benzoates; Bone Density; Bone Resorption; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Intestinal Absorption; Male; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroidectomy; Rats; Rats, Sprague-Dawley; Rats, Wistar; Retinoids; Thyroidectomy

1993